Haval Shirwan

Affiliations: 
University of Louisville, Louisville, KY, United States 
Area:
Immunology, Biochemistry, Molecular Biology
Google:
"Haval Shirwan"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Coronel MM, Martin KE, Hunckler MD, et al. (2020) Immunotherapy via PD-L1-presenting biomaterials leads to long-term islet graft survival. Science Advances. 6: eaba5573
Shrestha P, Batra L, Tariq Malik M, et al. (2020) Immune checkpoint CD47 molecule engineered islets mitigate instant blood-mediated inflammatory reaction and show improved engraftment following intraportal transplantation. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Batra L, Shrestha P, Zhao H, et al. (2020) Localized Immunomodulation with PD-L1 Results in Sustained Survival and Function of Allogeneic Islets without Chronic Immunosuppression. Journal of Immunology (Baltimore, Md. : 1950)
Shirwan H, Batra L, Malik MT, et al. (2020) Abstract 4516: SA-4-1BBL as a novel agonist of CD137 has immunoprevention efficacy against various tumor types Immunology. 80: 4516-4516
Batra L, Shrestha P, Zhao H, et al. (2020) Immunomodulation With Sa-Pdl1 Protein On Pancreatic Islets Promotes Indefinite Graft Survival In Allogeneic Recipients Transplantation. 104
Woodward KB, Zhao H, Shrestha P, et al. (2019) Pancreatic islets engineered with a FasL protein induce systemic tolerance at the induction phase that evolves into long-term graft-localized immune privilege. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Yerneni SS, Lathwal S, Shrestha P, et al. (2019) Rapid On-Demand Extracellular Vesicle Augmentation with Versatile Oligonucleotide Tethers. Acs Nano
Bowen W, Batra L, Pulsifer AR, et al. (2019) Robust Th1 cellular and humoral responses generated by the Yersinia pestis rF1-V subunit vaccine formulated to contain an agonist of the CD137 pathway do not translate into increased protection against pneumonic plague. Vaccine
Barsoumian HB, Batra L, Shrestha P, et al. (2019) A Novel Form of 4-1BBL Prevents Cancer Development via Nonspecific Activation of CD4 T and Natural Killer Cells. Cancer Research. 79: 783-794
Shirwan H, Barsoumian HB, Batra L, et al. (2019) Abstract 4145: A novel form of 4-1BB agonist shows robust immune protection against various tumor types through CD4+memory-like T and NK cell axis Cancer Research. 79: 4145-4145
See more...